Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Jun 1;354(22):2340-8.
doi: 10.1056/NEJMoa054391.

Body-mass index and symptoms of gastroesophageal reflux in women

Affiliations

Body-mass index and symptoms of gastroesophageal reflux in women

Brian C Jacobson et al. N Engl J Med. .

Abstract

Background: Overweight and obese persons are at increased risk for gastroesophageal reflux disease. An association between body-mass index (BMI)--the weight in kilograms divided by the square of the height in meters - and symptoms of gastroesophageal reflux disease in persons of normal weight has not been demonstrated.

Methods: In 2000, we used a supplemental questionnaire to determine the frequency, severity, and duration of symptoms of gastroesophageal reflux disease among randomly selected participants in the Nurses' Health Study. After categorizing women according to BMI as measured in 1998, we used logistic-regression models to study the association between BMI and symptoms of gastroesophageal reflux disease.

Results: Of 10,545 women who completed the questionnaire (response rate, 86 percent), 2310 (22 percent) reported having symptoms at least once a week, and 3419 (55 percent of those who had any symptoms) described their symptoms as moderate in severity. We observed a dose-dependent relationship between increasing BMI and frequent reflux symptoms (multivariate P for trend <0.001). As compared with women who had a BMI of 20.0 to 22.4, the multivariate odds ratios for frequent symptoms were 0.67 (95 percent confidence interval, 0.48 to 0.93) for a BMI of less than 20.0, 1.38 (95 percent confidence interval, 1.13 to 1.67) for a BMI of 22.5 to 24.9, 2.20 (95 percent confidence interval, 1.81 to 2.66) for a BMI of 25.0 to 27.4, 2.43 (95 percent confidence interval, 1.96 to 3.01) for a BMI of 27.5 to 29.9, 2.92 (95 percent confidence interval, 2.35 to 3.62) for a BMI of 30.0 to 34.9, and 2.93 (95 percent confidence interval, 2.24 to 3.85) for a BMI of 35.0 or more. Even in women with a normal baseline BMI, an increase in BMI of more than 3.5, as compared with no weight changes, was associated with an increased risk of frequent symptoms of reflux (odds ratio, 2.80; 95 percent confidence interval, 1.63 to 4.82).

Conclusions: BMI is associated with symptoms of gastroesophageal reflux disease in both normal-weight and overweight women. Even moderate weight gain among persons of normal weight may cause or exacerbate symptoms of reflux.

PubMed Disclaimer

Figures

Figure 1
Figure 1
GERD symptoms were defined as heartburn (“a burning pain or discomfort behind the breast bone in your chest”) and/or acid regurgitation (“a bitter or sour-tasting fluid coming into your throat or mouth”). Frequent GERD symptoms were those occurring at least weekly. Multivariate ORs are based upon 2,306 cases and 3,904 controls and have been adjusted for age; smoking status; total activity; daily caloric intake; alcohol intake; coffee, tea, and chocolate consumption; post-menopausal hormone therapy; anti-hypertension medication use; asthma medication use; and diabetes mellitus. *Odds Ratio (OR: 95% CI) of body mass index (BMI) by 7 categories for women who had GERD symptoms within last year. Multivariate model was adjusted for age, total activity (METS/Wk), anti-hypertension medication use, asthma medication use in past 12 months, history of diabetes, depression, stress from care, total coffee and tea consumption, total caffeine, alcohol intake, regular soft drink, diet soft drink, juice, fruit punch, smoke status, HRT, aspirin use, other NSAID use, acetaminophen use, trans fat, saturated fat, polyunsaturated fat, monounsaturated fat, omega 3 acid, total protein, total carbohydrate, total calorie intake, chocolate, fruit and vegetable, antilog AOAC fiber and salt. *Odds Ratio (OR: 95% CI) of body mass index (BMI) by 7 categories for women who had at least weekly GERD symptoms. Multivariate model was adjusted for age, total activity (METS/Wk), anti-hypertension medication use, asthma medication use in past 12 months, history of diabetes, depression, stress from care, total coffee and tea consumption, total caffeine, alcohol intake, regular soft drink, diet soft drink, juice, fruit punch, smoke status, HRT, aspirin use, other NSAID use, acetaminophen use, trans fat, saturated fat, polyunsaturated fat, monounsaturated fat, omega 3 acid, total protein, total carbohydrate, total calorie intake, chocolate, fruit and vegetable, antilog AOAC fiber and salt.
Figure 1
Figure 1
GERD symptoms were defined as heartburn (“a burning pain or discomfort behind the breast bone in your chest”) and/or acid regurgitation (“a bitter or sour-tasting fluid coming into your throat or mouth”). Frequent GERD symptoms were those occurring at least weekly. Multivariate ORs are based upon 2,306 cases and 3,904 controls and have been adjusted for age; smoking status; total activity; daily caloric intake; alcohol intake; coffee, tea, and chocolate consumption; post-menopausal hormone therapy; anti-hypertension medication use; asthma medication use; and diabetes mellitus. *Odds Ratio (OR: 95% CI) of body mass index (BMI) by 7 categories for women who had GERD symptoms within last year. Multivariate model was adjusted for age, total activity (METS/Wk), anti-hypertension medication use, asthma medication use in past 12 months, history of diabetes, depression, stress from care, total coffee and tea consumption, total caffeine, alcohol intake, regular soft drink, diet soft drink, juice, fruit punch, smoke status, HRT, aspirin use, other NSAID use, acetaminophen use, trans fat, saturated fat, polyunsaturated fat, monounsaturated fat, omega 3 acid, total protein, total carbohydrate, total calorie intake, chocolate, fruit and vegetable, antilog AOAC fiber and salt. *Odds Ratio (OR: 95% CI) of body mass index (BMI) by 7 categories for women who had at least weekly GERD symptoms. Multivariate model was adjusted for age, total activity (METS/Wk), anti-hypertension medication use, asthma medication use in past 12 months, history of diabetes, depression, stress from care, total coffee and tea consumption, total caffeine, alcohol intake, regular soft drink, diet soft drink, juice, fruit punch, smoke status, HRT, aspirin use, other NSAID use, acetaminophen use, trans fat, saturated fat, polyunsaturated fat, monounsaturated fat, omega 3 acid, total protein, total carbohydrate, total calorie intake, chocolate, fruit and vegetable, antilog AOAC fiber and salt.

Comment in

  • BMI and gastroesophageal reflux in women.
    Kostikas K, Papaioannou AI, Gourgoulianis KI. Kostikas K, et al. N Engl J Med. 2006 Aug 24;355(8):848; author reply 849-50. doi: 10.1056/NEJMc061773. N Engl J Med. 2006. PMID: 16929003 No abstract available.
  • BMI and gastroesophageal reflux in women.
    Yanai H, Yoshida H, Tada N. Yanai H, et al. N Engl J Med. 2006 Aug 24;355(8):848-9; author reply 849-50. N Engl J Med. 2006. PMID: 16937552 No abstract available.
  • BMI and gastroesophageal reflux in women.
    Etzel CJ, Kachroo S. Etzel CJ, et al. N Engl J Med. 2006 Aug 24;355(8):848; author reply 849-50. N Engl J Med. 2006. PMID: 16937553 No abstract available.

References

    1. Klauser A, Schindlbeck N, Muller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet. 1990;335:205–208. - PubMed
    1. Locke GR, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology. 1997;112:1448–1456. - PubMed
    1. El-Serag H, Petersen N, Carter J, et al. Gastroesophageal reflux among different racial groups in the United States. Gastroenterology. 2004;126:1692–1699. - PubMed
    1. Sandler R, Everhart J, Donowitz M, et al. The burden of selected digestive diseases in the United States. Gastroenterology. 2002;122:1500–1511. - PubMed
    1. Henke C, Levin T, Henning J, Potter L. Work loss costs due to peptic ulcer disease and gastroesophageal reflux disease in a health maintenance organization. Am J Gastroenterol. 2000;95:788–792. - PubMed

Publication types